The air compressor nebulizer market comprises medical
devices used for delivering medication through a compressed air-driven
nebulizer. The air compressor forces the medication into an aerosol (fine
mist), which can then be directly inhaled by the patient through a mask or
mouthpiece. Key features and advantages of using air compressor nebulizers
include improved effectiveness over ultrasonic nebulizers, ability to
administer multiple respiratory therapies simultaneously, portability and
durability. The growing incidence of respiratory diseases such as asthma and
chronic obstructive pulmonary disease (COPD) has significantly driven the
demand for air compressor nebulizer globally.
The
Global air compressor nebulizer market is estimated to be valued at US$ 1,550.1
Mn in 2024 and is expected to exhibit a CAGR of 7.5% over the forecast period
2024 to 2031.
Key Takeaways
Key players operating in the air compressor nebulizer market are Agilent
Technologies, Omron Corporation, PARI GmbH, Philips Respironics, Medline
Industries Inc., Yuwell, 3A Health Care, GF Health Products, Inc., Briggs
Healthcare, Beurer GmbH, Medquip Inc., Teleflex Incorporated, Invacare
Corporation, Vyaire Medical Inc., Rossmax International Ltd., A&D Medical,
and Apex Medical Corp. The major players are focusing on new product launches
and geographic expansion strategies to strengthen their market presence.
The rising prevalence of respiratory diseases due to increasing pollution
levels and growing aging population presents lucrative growth opportunities for
players in the
Air
Compressor Nebulizer Market Demand. According to WHO, over 65 million
people suffer from moderate to severe COPD worldwide. Additionally, the global
asthma patient pool is estimated to reach over 600 million by 2022.
Major players are expanding their global footprint, especially in developing nations
to tap the large untapped growth potential in Asian and Latin American
countries. For instance, in March 2022, GF Health Products expanded its
manufacturing footprint in India through its subsidiary Omron Healthcare India.
Market drivers:
- Growing prevalence of respiratory diseases such as asthma and COPD owing
to factors like increasing pollution levels and aging population.
- Advantages over conventional jet nebulizers such as higher efficiency and
ability to deliver multiple medications simultaneously.
- Technological advancements introducing smart, portable nebulizers with added
functionality.
Market restraints:
- High costs associated with advanced air compressor nebulizers limiting
widespread adoption.
- Preference for alternative drug delivery methods such as metered dose
inhalers and dry powder inhalers in certain cases.
- Issues with bulk and portability due to requirement of an external compressor
unit.
Segment
Analysis
The Air Compressor Nebulizer market can be segmented
based on technology, end user and geography. Based on technology, the market
can be segmented into Pneumatic nebulizers and ultrasonic nebulizers. Pneumatic
nebulizers dominate the market currently due to their lower price and ease of
use. Pneumatic nebulizers are more portable and have a compact design. They
have better efficiency in drug delivery to the lungs. Ultrasonic nebulizers are
expected to gain market share in the forecast period due to advantages like
silent operation, less residual volume and ability to nebulize heat-sensitive
drugs and viscous drugs.
Based on end user, the air compressor nebulizer market can be segmented into
hospitals and clinics, home healthcare and others. The hospitals and clinics
segment currently dominates the market due to large patient pool and
availability of advanced devices. However, the home healthcare segment is
expected to grow at a higher CAGR during the forecast period supported by
growing preference for home healthcare due to comfort of patients and cost
effectiveness.
Global Analysis
North America currently dominates the air compressor nebulizer market
supported by high healthcare expenditure, growing cases of respiratory diseases
and presence of key players. However, Asia Pacific is expected to grow at the
highest CAGR during the forecast period due to growing medical tourism,
increasing geriatric population, improving healthcare infrastructure and rising
disposable income in the region.
Get
more insights on Air
Compressor Nebulizer Market
About Author:
Money Singh is a seasoned content writer with over
four years of experience in the market research sector. Her expertise spans
various industries, including food and beverages, biotechnology, chemical and
materials, defense and aerospace, consumer goods, etc. (https://www.linkedin.com/in/money-singh-590844163)
Comments
Post a Comment